Steven Liberty, senior vice president of operations for Patheon's
North American businesses spoke at Interphex on the strategies
contract manufacturing organisations (CMOs) can use to obtain a
competitive advantage.
SGS has officially launched a new auditing service designed to
alleviate the quality, regulatory and safety issues in
pharmaceutical supply chains, which are increasingly extending
across the globe.
Pharmaceutical manufacturers, distributors and retailers alike have
welcomed a unanimous vote by the California State Board of Pharmacy
to delay for another two years the implementation of electronic
pedigree requirements for tracking...
The globalisation of the supply chain increasingly challenges the
US Food and Drug Administration's ability to ensure the quality of
pharmaceuticals on the US market, acknowledges the acting director
of the agency's Center...
US contract manufacturer Catalent Pharma Solutions has leveraged
its partnership with Secure Symbology (SSI) for track and trace
barcode technology to help biopharmaceutical company Biogen Idec
comply with California's pending...
A new enterprise in the United Arab Emirates (UAE) is establishing
itself as the region's first pharmaceutical-focused third party
logistics (3PL) provider.
The first steps in tightening the safety controls on the
pharmaceutical ingredients imported to the US from China have been
taken following months of negotiations between the regulatory
bodies of the two countries.
Bristol-Myers Squibb (BMS) has finally detailed its plans to trim
the fat and save cash, months after first revealing that big
changes would be on the cards.
Recipharm has come to rescue of UK-based Ashton Pharma, which has
been nervously awaiting to discover its fate, having spent five
months in administration after its former owners Inyx Inc. suffered
major financial woes.
A new report highlights a number of worrying trends emerging in
regard to the increasing number of fake pharmaceuticals
infiltrating supply chains around the globe.
GlaxoSmithKline (GSK) and Merck Sharp & Dohme (MSD) have made
further moves in their plans to boost their presence in Singapore,
a region growing in popularity for biopharmaceutical research and
manufacture.
Kuehne + Nagel (K + N) has inked a new pact with UK-based drug
maker AstraZeneca to provide the global cold chain air and sea
freight for some of its products.
In a round-up of motley pharmaceutical services news,
Outsourcing-Pharma takes a look at recent announcements involving
Quintiles, Kenexa, Atos, Catalent Pharma, Patni and Taratec.
British contract manufacturing organisation (CMO) NextPharma
Technologies has announced a €30m fundraising round and the
acquisition of Bioserv, another CMO based in the US.
AstraZeneca has sold a manufacturing plant in France to a contract
manufacturer who will continue to supply the drug giant with its
products under a new outsourcing contract.
Despite a lift of the ban on biological sample transportation out
of Russia, the country's clinical research industry is still in the
dark on the new rules to control export of such materials.
In a round-up of motley pharmaceutical services contracts,
Outsourcing-Pharma takes a look at recent news involving Movianto,
PDI, inVentiv Health and Exel.
The pharmaceutical and healthcare industries will help to push
trade between India and the United Kingdom up by 60 per cent within
three years, claims a soon-to-be released report.
The European Commission has released figures showing that there has
been a dramatic and concerning increase in pharmaceutical
counterfeiting, with seizures in Europe hitting an all time high of
over 2.5m items.
British drug maker AstraZeneca has awarded UK-based NYK Logistics a
two and a half year contract for the distribution of its drugs
throughout Europe, worth £6m (€8.9m).
A magic bullet for the pharmaceutical supply chain has entered the
stage as radio frequency identification (RFID) technology attempts
to fix up its teething problems.
Albany Molecular Research (AMRI) has followed up its push into new
markets for its drug discovery operations by tapping into the
well-established trend for sourcing contract pharmaceutical
manufacturing from the lower-cost Asian region.
A UK-based technology company is part of a trio leading the way in
innovative supply chain solutions by combining real-time
temperature monitoring with a radio frequency identification (RFID)
tag for the pharmaceutical industry.
Contract logistics provider Kuehne + Nagel (K+N) has announced it
is expanding its capacity in Dubai in a bid to provide a global hub
for pharmaceutical companies.
In-PharmaTechnologist takes an indepth look at the new radio
frequency identification (RFID) technology that will soon
revolutionise pharmaceutical supply chain management.
The burgeoning Japanese pharmaceutical market is set to boost the
third party logistics (3PL) sector as drug makers are expected to
increase their reliance on outsourcing for this type of services in
the future, a new report said.
Movianto has more than doubled its pharmaceutical storage capacity
at two of its European sites with the construction of two new
warehouses, in answer to increased demand.
This year is shaping up to be another good year for third party
logistics (3PL) services firms focused on the pharmaceutical
industry, according to Sentry.
Shipping giant DHL has bagged a lucrative contract with pharma
giant Wyeth and become the first logistics provider to be given
complete responsibility for a company's worldwide clinical trial
materials distribution.
A number of executives and technical staff at small to medium size
pharmaceutical firms are unaware of how to use their resources
effectively to comply with new EMEA guidelines, designed to
minimise the environmental impact of compounds,...
Pharmaceutical companies are beginning to catch up with other
industry sectors that take an increasingly realistic view of what
they consider a core competency and outsourcing what is left -
Outsourcing-Pharma takes a snapshot of...
Although manufacturing is the most established of the pharma
outsourcing segments, many service areas are still rapidly
evolving. OutsourcingPharma.com gives a brief run down of the
current state of play.
Firms engaging in both in-house and contract pharma manufacturing
generally display inferior performance compared to manufacturers
conducting only in-house production, according to new research.
Drug makers need to put in place greater cold chain management
capacity, in house or by outsourcing the service, as the biotech
market continues to boom.
The market for radiofrequency identification (RFID) tags in
healthcare is set to explode from $90m (€70m) in 2006 to $2.1bn in
2016, driven by the item level tagging of drugs and the growing
appeal of "smart packaging."
Jacobs Engineering Group has inked a new contract with Boehringer
Ingelheim to provide technical and construction services for its
new bulk active pharmaceutical ingredient (API) facility being
built in Petersburg, Virginia, US.
Sentry Logistic Solutions has launched an additional service,
offering to build customised drug storage facilities for
pharmaceutical companies with special needs.
Europe's third party logistics providers (3PL) are evolving to
integrate more of their operations with those of their clients in a
bid to provide a more efficient service, leaving the old breed in
danger of becoming extinct.
French Healthcare logistics firm DGX Pharma has won a new
multi-year contract from Japan's Sankyo Pharma to provide logistics
and distribution services for its drug products in the French
market.
Nomeco, Denmark's biggest pharma wholesaler, has won a large
pre-wholesaling and logistics contract with Iceland's Actavis
covering the Nordic countries, typifying the regional shift in this
evolving sector of pharmaceutical...
FFF Enterprises has just been awarded a new contract to distribute
GlaxoSmithKline's (GSK's) flu vaccine in the US, making it the
largest flu vaccine distributor for the second year running.
Pharmaceutical wholesalers in Europe need to evolve to meet the
changing pharma market and a world of opportunity awaits for those
willing to think beyond their traditional business model and move
to compete in the outsourcing arena.
Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...
